Serum beta-glucuronidase activity was estimated by our modified method using two substrates phenolphthalein glucuronide and p-nitrophenyl glucoronide in 49 healthy subjects and 94 patients with gastrointestinal tract (GIT) carcinoma. The correlation coefficient using the two substrates was found to be r=0.8383. The method of Gabor Szasz was modified wherein the incubation time was decreased from 5 hours to 2 hours and the incubation temperature was increased from 25~ to 37~ The increase in beta-glucuronidase activity in GIT carcinoma appears to be a good biochemical marker in patients with such type of carcinomas, a finding not reported in literature to-date.
INTRODUCTION
The interest of beta-glucuronidase has increased and its relationship to neoplastic disease has been usually indicated by the finding of markedly enhanced activity of this enzyme in breast carcinomas and involved lymph nodes, in gastric, bowel, and metastatic carcinomas than in normal uninvolved tissue (1, 2) , in superficial cancer and papilloma of bladder (3) and also in lymphocytes from patients with carcinoma of GIT (4) . Elevated levels of lactate dehydrogenase and beta-glucuronidase are found in gastric juice of patients with gastric cancer (5) and urine of patients with urinary tract malignancy (6) and hence this enzyme can be used as a screening test for such malignancies.
Beta-glucuronidase actMty is determined bythe method of Fishman et al (7) using phenolphthalein glucuronide and by Gabor Szasz (8) using p-nitrophenyl glucuronide synthesized by Kato et al (9) and phenolphthalein glucuronide.
In a study of patients with gastrointestinal carcinomas and normal healthy subjects we included the measurement of beta-gfucuronidase activity to establish whether the two methods modified by reducing the incubation time to 2 hours and increasing incubation temperature from 25~ to 37~ gave comparable results.
MATERIALS AND METHODS
Estimation of beta-glucuronidase was performed on the serum samples of 49 healthy subjects and 94 patients with gastrointestinal tract carcinoma of which 47 patients were cancer of oesophagus, 20 patients with cancer of stomach, 20 patients with cancer of rectum and 7 patients with cancer of colon. All the patients studied had histological evidence of malignancy and were those referred to the Tata Memorial Hospital, Mumbai for investigation and management.
The samples were analysed on the same day after separation of the serum. Haemolysed sera were not included in the study. The beta-glucuronidase activity was determined earlier by the method of Gabor Szasz (8) using two substrates, phenolphthalein glucuronide and p-nitrophenyl glucuronide obtained from Sigma Chemicals Co., U.S.A. The method incubation period to 2 hours and increasing the temperature from 25~ to 37~ The system for the assay of beta-glucuronidase consisted of 0.2 ml of acetate buffer (0.2M, pH 5.0), 1.0 ml of glycine (0.6M, pH 11.7), 0.1 ml serum and 0.1 ml of either phenolphthalein glucuronide (15 mM) or p-nitrophenyl glucuronide (50 mM) as substrate with appropriate serum and reagent blanks. After incubation at 37~ for2 hours, absorbance at 546 nm was read in Schimadzu UV 160 spectrophotometer against water blank.
The activity is expressed in milliunits (mU=0.001 IU) using the equation--106 TV 1 mU = A x --(Asb + Arb) X X _m X E SV t in which Ax = absorbance of unknown sample, Asb = serum blank absorbance, t = incubation time, TV = total volume, SV = sample volume and E = molar absorptivity. Molar absorptivity of phenolphthalein 29,300 and that of p-nitrophenyl glucuronide 18,500. The amount of phenolphthalein and p-nitrophenol liberated was calculated using the above formula. Standard curve was plotted using the two substrates. Correlation coefficients and regression lines were calculated. Student's 't' test was used for statistical analysis.
RESULTS AND DISCUSSION
The values obtained for beta-glucuronidase using phenolphthalein glucuronide and p-nitrophenyl glucuronide as substrates in normal subjects were in the range of 0 . 2 6 0 . 7 3 mU/ml and 0.36~1.28 mU/ml with a mean value of 0.458 _+ 0.136 and 0.773 + 0.255 respectively (Table 1 ).
In patients with gastrointestinal carcinoma the beta-glucuronidase values using phenolphthalein glucuronide and p-nitrophenyi glucuronide as substrate ranged from 0.28--1.86 mU/ml and 0.42--5.37 mU/ ml with a mean of 0.7395 + 0.3085 and 1.666 + 0.9802 respectively ( Table 1) . These values are in close agreement with those reported by Gabor Szasz (8) .
The analysis of the data of 94 different samples from patients with gastrointestinal carcinoma and 49 healthy subjects were within the range expected from the coefficient of variation. Regression lines and correlation coefficient have been calculated. The existence of a linear correlation between the two substrates for estimating beta-glucuronidase was largely consistent throughout the range investigated. The regression line for phenolphthalein glucuronide and p-nitrophenyl glucuronide is y = 0.271x + 0.27 and r = 0.8383 confirming that in the group of subjects studied the variation of pnitrophenyl glucuronide parallels the corresponding variation in phenolphthelein glucuronide (Fig. 1) . Table 1 : Beta-glucuronidase activity using phenophthalein glucuronide and p-nitrophenylglucumnide substrates in normal subjects and in patients with gastrointestinal carcinoma.
Group
No. of The scatter of the data in the Fig. 1 showed a high degree of association and significance (p<0.001).
The results show that the increase in beta-glucumnidase activity is significant in GIT carcinomas and it appears that both p-nitrophenyl glucuronide and phenolphthelein glucuronide are equally useful in the determination of beta-glucuronidase activity in human serum. The presence of isoenzyrnes which could have split one of the substrates more quickly was contradicted by the strict linear relationship obtained. 
